This research study aims to evaluate the effect of a 6-month adapted physical activityprogram (APA) on the endurance capacities (evaluated as the maximum oxygen consumption[VO2 peak] on a cardiopulmonary exercise test) of children and adolescents with Marfansyndrome or related.
Marfan syndrome (MFS) is characterized by the association of multisystem damage related
to connective tissue fragility. The risk of aortic dissection has diverted attention from
significant musculoskeletal damage despite commonly reported extreme fatigue and pain
with impact on the patient's quality of life. In a recent study (Marfanpower,
NCT03236571), investigators have observed reduced endurance capacities in children and
teenagers with MFS (average VO2 peak at 60% of expected), which were significantly
increased by an intensive rehabilitation program. Based on this experience, investigators
aim to evaluate the effect of a physical activity program adapted to the daily life of
the young patients on their endurance capacities and their quality of life. This program
will be set up by an adapted physical activity (APA) coach after a complete assessment,
including a cardiopulmonary exercise test with VO2 peak measurement, which will be
carried out in the Reference Centre for Marfan syndrome at the Toulouse University
Hospital. The VO2 peak evolution will be evaluated after 6 months of program. This is a
recognized parameter for the evaluation of endurance and has been validated in children.
Investigators hypothesize that the implementation of a physical activity program adapted
to the daily life and interests of the child with MFS will efficiently improve endurance,
prevent deconditioning and promote long term benefits.
Other: Adapted Physical Activity program
The Adaptated Physical Activity program will consist of a Personalized Training Program
Inclusion Criteria:
- Genetically confirmed Marfan syndrome or related syndrome
- Girl or boy aged 7 to 17
- Informed and written consent signed by at least one of the two holders of parental
authority
- Patient affiliated to a social security scheme or equivalent
Exclusion Criteria:
- Cardiac contraindications to the APA program:
- Severe aortic dilation (aortic diameter > 45 mm)
- and/or left ventricular failure (left ventricular ejection fraction <45%)
- and/or severe mitral leakage ≥ grade 3
- Pregnancy
CHU Toulouse
Toulouse, France
Investigator: Thomas EDOUARD, MD
Thomas EDOUARD, MD
05 34 54 91 95
edouard.t@chu-toulouse.fr
Fernanda BAJANCA
bajanca.f@chu-toulouse.fr
Thomas EDOUARD, MD, Principal Investigator
CHU Toulouse